DaBomb Protein Biotech Corp.
TWO: 6578.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- CEO
- Wei Chen Chen
- Employees
- 46
- Headquarters
- Tainan, Taiwan
- IPO year
- 2016
- Market cap
- NT$1.1B
- Website
- https://www.dabombprotein.com
Loading 6578…
Loading profile data…Frequently asked questions about 6578
What does DaBomb Protein Biotech Corp. (6578.TWO) do?
DaBomb Protein Biotech Corp., a specialized biotech company, primarily engages in the development of antibiotics alternatives in animal health industry. It offers plant protein, including DaBomb-P (Aqua) and DaBomb-P (Livestock); antibiotics alternatives, such as DBT-100 HT and DBT-100 LS; and pet care products comprising LACTOTIDES HEALTH A+ an...
Where does 6578.TWO trade?
DaBomb Protein Biotech Corp. (6578.TWO) trades on the Taipei Exchange.
What sector is 6578.TWO in?
DaBomb Protein Biotech Corp. (6578.TWO) operates in the Consumer Defensive sector, specifically in the Packaged Foods industry.
Who is the CEO of DaBomb Protein Biotech Corp.?
Wei Chen Chen is the chief executive officer of DaBomb Protein Biotech Corp. (6578.TWO).
Where is DaBomb Protein Biotech Corp. headquartered?
DaBomb Protein Biotech Corp. is headquartered in Taiwan.
Does 6578.TWO pay a dividend?
Yes — DaBomb Protein Biotech Corp. (6578.TWO) paid a trailing twelve-month dividend of TWD 0.40 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 6578.TWO go public?
DaBomb Protein Biotech Corp. (6578.TWO) completed its initial public offering in 2016.